Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
______________________
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
 
Date of Report (Date of earliest event reported)   June 30, 2013
 
RETROPHIN, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
000-53293
26-2383102
(State or other jurisdiction
of incorporation)
(Commission
File Number)
 
(I.R.S. Employer
Identification No.)
777 Third Avenue, Suite 22, New York, NY
10017
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code    (212) 983-1310
 
 
(Former name or former address, if changed since last report.)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
¨ 
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ 
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ 
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ 
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c))
 
 
 

 
 
Item 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

As of June 30, 2013, Retrophin, Inc. (the “Company”) and Marc Panoff entered into an amendment (the “Amendment”) to the Employment Agreement, dated as of May 7, 2013, pursuant to which the initial vesting of a pro rata portion of the restricted common stock granted under the Employment Agreement was changed from June 30, 2013 to December 31, 2013. All other terms of the Employment Agreement remain in full force and effect.
 
The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the Amendment, which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.
 
Item 9.01.
  Financial Statements and Exhibits.
 
Exhibits:
 
10.1
Amendment to Employment Agreement, dated as of June 30, 2013.
 
 
 

 
 
SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
RETROPHIN, INC.
 
       
Date:  July 29 , 2013
By:
/s/ Martin Shkreli  
   
Name:  Martin Shkreli
 
   
Title:    Chief Executive Officer
 
       
Unassociated Document
AMENDMENT TO EMPLOYMENT AGREEMENT

 
THIS AMENDMENT TO THE EMPLOYMENT AGREEMENT is entered into as of June 30, 2013 (this “Amendment”), by and between RETROPHIN, INC., a Delaware corporation  (the “Company”), and Marc Panoff (the “Executive,” together with the Company, the “Parties”).
 
WHEREAS, the Parties entered into that certain Employment Agreement, dated as of May 7, 2013 (the “Agreement”);
 
WHEREAS, the Parties hereby amend the vesting schedule of the common stock granted pursuant to the Agreement; and
 
WHEREAS, Section 12 of the Agreement provides that the Agreement may be amended only by a written agreement of the Parties.
 
NOW, THEREFORE, in consideration of the premises and the mutual covenants hereinafter contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:
 
1.           All capitalized terms used but not otherwise defined herein have the meanings given to them in the Agreement.

2.           The Agreement is hereby amended by deleting Section 3(f) thereof and replacing it in its entirety with the following:

Equity.  In addition to the Annual Base Salary, the Executive shall be granted, on and subject to the terms and conditions of an award agreement to be entered into between the Executive and Company (it being understood that such grant shall be conditioned upon the execution of such award agreement), 120,000 units of restricted common stock of the Company (the “Incentive Compensation”), a pro rata portion of which shall vest initially on December 31, 2013 and each quarter thereafter until the third anniversary of the execution of this Agreement; provided, however, that if the Executive is no longer employed by the Company, any Incentive Compensation that has not vested prior to the date of termination shall be immediately cancelled and not subject to further vesting.”

3.           Except as set forth expressly herein, all terms of the Agreement, as amended hereby, shall be and remain in full force and effect and shall constitute the legal, valid, binding and enforceable obligations of the Parties.  The execution, delivery and effectiveness of this Amendment shall not, except as expressly provided herein, operate as a waiver of any right, power or remedy of the Parties under the Agreement, nor constitute a waiver of any provision of the Agreement.
 
 
1

 
 
4.           This Amendment shall be governed by, and construed in accordance with, the internal laws of the State of New York and all applicable federal laws of the United States of America.

5.           This Amendment may be executed by one or more of the Parties hereto in any number of separate counterparts, each of which shall be deemed an original and all of which, taken together, shall be deemed to constitute one and the same instrument.  Delivery of an executed counterpart of this Amendment by facsimile transmission or electronic transmission shall be as effective as delivery of a manually executed counterpart hereof.

6.           This Amendment shall be binding upon and inure to the benefit of the Parties hereto, their respective successors, successors-in-titles, and assigns.

7.           This Amendment sets forth the entire understanding of the Parties with respect to the matters set forth herein, and shall supersede any prior negotiations or agreements, whether written or oral, with respect thereto.

 [Signature page follows.]
 
 
2

 
 
IN WITNESS WHEREOF, the parties hereto have executed this Amendment on the date first above written.
 
 
RETROPHIN, INC.
 
       
 
By:
/s/ Martin Shkreli  
    Name: Martin Shkreli  
    Title:   Chief Executive Officer  
       
       
  EXECUTIVE:  
       
       
    /s/ Marc Panoff  
    Marc Panoff  
       
 
3